US2015193593A1PendingUtilityA1

Patient customized therapeutic regimens

Assignee: PROTEUS DIGITAL HEALTH INCPriority: May 2, 2006Filed: Dec 29, 2014Published: Jul 9, 2015
Est. expiryMay 2, 2026(expired)· nominal 20-yr term from priority
A61B 5/073Y10S128/92A61B 5/4833A61B 5/0002A61B 5/4848Y10S128/903H01M 2220/10H04B 13/005A61B 5/0028G16H 50/20H01M 8/02G06F 19/3456G06F 19/345G16H 10/60G16H 20/10G06Q 10/00G16H 40/67Y02E60/10Y02E60/50
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods, systems and compositions that allow for treating a patient according to a patient customized therapeutic regimen are provided. Embodiments of the invention include obtaining dosage administration information from a patient and using the same to tailor a therapeutic regimen for the patient. Embodiments of the invention further include preparing and forwarding to the patient physical pharmaceutical dosages based on the customized therapeutic regimen.

Claims

exact text as granted — not AI-modified
1 - 32 . (canceled) 
     
     
         33 . A method of managing a therapeutic regimen for treatment of a patient, the method comprising:
 receiving confirmatory data from a first device associated with a patient by a second device associated with a body of the patient when a therapeutic regimen associated with the first device is administered to the patient and when communication is initiated by the first device upon contact with a body of the patient, wherein the first device is electrically coupled to the body of the patient, wherein the confirmatory data represents administration of a medical composition to the body of the patient, wherein the confirmatory data is produced by the first device and is conductively communicated to the second device in contact with the body of the patient;   evaluating the confirmatory data;   determining whether a change in the therapeutic regimen is desired; and   modulating the therapeutic regimen upon determining that the change in the therapeutic regimen is desired.   
     
     
         34 . The method of  claim 33 , wherein receiving the confirmatory data from the first device comprises receiving the confirmatory data from the first device when the first device is ingested by the patient and the first device is activated upon contact with an electrically conductive body fluid via completion of a partial power source, and wherein the confirmatory data represents the ingestion of the pharmaceutical dosage of the medical composition by the patient. 
     
     
         35 . The method of  claim 33 , wherein the second device is electrically coupled to the body. 
     
     
         36 . The method of  claim 33 , further comprising transmitting a signal representative of the confirmatory data from the first device to the second device, wherein the signal is established by an electrical current between the first and second devices. 
     
     
         37 . The method of  claim 36 , further comprising confining the electrical current within the first and second devices and the body. 
     
     
         38 . The method of  claim 36 , further comprising confining the electrical current among the first and second devices, wherein the first and second devices are each capacitively coupled to a conductor external to the patient or ground external to the patient. 
     
     
         39 . The method of  claim 33 , further comprising automatically receiving the confirmatory data at the second device. 
     
     
         40 . The method of  claim 33 , wherein the first and second devices are different types of devices. 
     
     
         41 . The method of  claim 40 , wherein the first device comprises an active agent. 
     
     
         42 . The method of  claim 33 , further comprising transmitting a second set of confirmatory data from a third device to the second device. 
     
     
         43 . The method of  claim 42 , wherein the third device comprises an active agent. 
     
     
         44 . The method of  claim 33 , wherein the first device comprises an identifier associated with a pharmaceutical composition, the method further comprising producing the confirmatory data by the identifier upon contact with a target physiological site of the patient. 
     
     
         45 . The method of  claim 33 , wherein the evaluating comprises inputting the data into a decision support tool and obtaining from the decision support tool a recommendation based on the confirmatory data as to whether a change in the therapeutic regimen is desirable. 
     
     
         46 . The method of  claim 33 , wherein evaluating the confirmatory data comprises assessing physiological data obtained from the patient. 
     
     
         47 . The method of  claim 33 , wherein evaluating the confirmatory data comprises at least one of assessing lifestyle information obtained from the patient or assessing physiological data obtained from the patient. 
     
     
         48 . The method of  claim 33 , further comprising providing a recommendation based on the evaluating by a health care practitioner. 
     
     
         49 . The method of  claim 48 , further comprising reviewing the recommendation to determine whether a change in the therapeutic regimen is to be made prior to changing the therapeutic regimen. 
     
     
         50 . A system for managing a therapeutic regimen for treatment of a patient, the system comprising:
 an input manager configured to receive confirmatory data produced by a first device associated with a patient when a therapeutic regimen associated with the first device is administered to the patient, wherein the confirmatory data represents administration of a medical composition to a body of the patient;   a processing module comprising a therapeutic regimen evaluator configured to assess a therapeutic regimen based on the received confirmatory data, wherein the processing module is configured to determine whether a change in a therapeutic regimen is desirable and provide a recommendation based on the determination; and   an output manager coupled to the processing module, the output manager configured to provide the recommendation to a user.   
     
     
         51 . The system of  claim 50 , wherein the input manager is configured to receive physiological data provided by a second device, wherein the physiological data indicates a response of the patient to a pharmaceutical dosage of the medical composition, wherein the second device is electrically coupled external to the body of the patient. 
     
     
         52 . The system of  claim 50 , further comprising a wireless communication device configured to receive the confirmatory data from a second device that is configured to communicate with the first device and configured to relay the received confirmatory data.

Join the waitlist — get patent alerts

Track US2015193593A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.